PH25019A - New benzamides and their use in treating gastrointestinal disorders - Google Patents

New benzamides and their use in treating gastrointestinal disorders

Info

Publication number
PH25019A
PH25019A PH34096A PH34096A PH25019A PH 25019 A PH25019 A PH 25019A PH 34096 A PH34096 A PH 34096A PH 34096 A PH34096 A PH 34096A PH 25019 A PH25019 A PH 25019A
Authority
PH
Philippines
Prior art keywords
gastrointestinal disorders
treating gastrointestinal
new benzamides
benzamides
new
Prior art date
Application number
PH34096A
Other languages
English (en)
Inventor
Armando Vega-Noverola
Jose Manuel Prieto-Soto
Fernando Pujol-Noguera
Jacinto Moragues-Mauri
Robert Geoffrey Willi Spickett
Original Assignee
Fordonal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordonal Sa filed Critical Fordonal Sa
Publication of PH25019A publication Critical patent/PH25019A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH34096A 1985-08-06 1986-08-04 New benzamides and their use in treating gastrointestinal disorders PH25019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519707A GB8519707D0 (en) 1985-08-06 1985-08-06 Chemical compounds

Publications (1)

Publication Number Publication Date
PH25019A true PH25019A (en) 1991-01-28

Family

ID=10583372

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34096A PH25019A (en) 1985-08-06 1986-08-04 New benzamides and their use in treating gastrointestinal disorders

Country Status (28)

Country Link
US (1) US4772618A (pt)
EP (1) EP0213775B1 (pt)
JP (1) JPH0662614B2 (pt)
KR (1) KR920001763B1 (pt)
CN (1) CN1022830C (pt)
AR (2) AR243521A1 (pt)
AT (1) ATE49206T1 (pt)
AU (1) AU596110B2 (pt)
CA (1) CA1300154C (pt)
DD (1) DD287502A5 (pt)
DE (1) DE3667975D1 (pt)
DK (1) DK370586A (pt)
EG (1) EG18154A (pt)
ES (2) ES2000706A6 (pt)
FI (1) FI89168C (pt)
GB (1) GB8519707D0 (pt)
GR (1) GR862060B (pt)
HU (1) HU201060B (pt)
IE (1) IE58751B1 (pt)
IL (1) IL79469A0 (pt)
MX (1) MX3375A (pt)
MY (1) MY101352A (pt)
NO (1) NO168706C (pt)
NZ (1) NZ217078A (pt)
PH (1) PH25019A (pt)
PL (1) PL150228B1 (pt)
PT (2) PT83146B (pt)
ZA (1) ZA865537B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JP2999669B2 (ja) * 1993-08-24 2000-01-17 株式会社三和化学研究所 ベンゾ[b]フランカルボキサミド誘導体、その製法及び用途
JPH0820586A (ja) 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd 1−アザビシクロ[3.3.0]オクタン誘導体、その塩及び製法並びに用途
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
CN1052228C (zh) * 1996-01-17 2000-05-10 中国科学院大连化学物理研究所 N-甲酰基哌啶及其同系物的制备方法
CN1091104C (zh) * 1998-04-02 2002-09-18 中国科学院大连化学物理研究所 一种n-甲酰基哌啶的制备方法
WO2003104069A1 (ja) 2002-06-01 2003-12-18 あき電器株式会社 自転車の前照灯及び前照灯電気回路
ATE464308T1 (de) * 2004-01-07 2010-04-15 Aryx Therapeutics Stereoisomere verbindungen und verfahren zur behandlung von erkrankungen des magen-darm-trakts und des zentralen nervensystems
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
JP5845263B2 (ja) * 2010-09-01 2016-01-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap 5−ht2b受容体アンタゴニスト
CN110950843B (zh) * 2019-11-28 2022-12-27 广东东阳光药业有限公司 取代的苯酰胺衍生物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1019781A (pt) 1963-03-05
US3342826A (en) 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
GB1507462A (en) * 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives

Also Published As

Publication number Publication date
HU201060B (en) 1990-09-28
PT83146B (pt) 1988-07-29
EP0213775B1 (en) 1990-01-03
GB8519707D0 (en) 1985-09-11
PT83147B (pt) 1988-07-29
NZ217078A (en) 1989-01-27
KR870002071A (ko) 1987-03-28
GR862060B (en) 1986-12-24
EP0213775A1 (en) 1987-03-11
PL260921A1 (en) 1988-01-07
FI89168C (fi) 1993-08-25
AR243521A1 (es) 1993-08-31
JPH0662614B2 (ja) 1994-08-17
ATE49206T1 (de) 1990-01-15
AR242793A1 (es) 1993-05-31
AU596110B2 (en) 1990-04-26
NO168706B (no) 1991-12-16
FI863179A0 (fi) 1986-08-04
ES2000705A6 (es) 1988-03-16
KR920001763B1 (ko) 1992-03-02
NO168706C (no) 1992-03-25
PT83146A (en) 1986-09-01
CA1300154C (en) 1992-05-05
JPS62129279A (ja) 1987-06-11
NO863139D0 (no) 1986-08-04
HUT44782A (en) 1988-04-28
IL79469A0 (en) 1986-10-31
IE58751B1 (en) 1993-11-03
EG18154A (en) 1992-11-30
US4772618A (en) 1988-09-20
DK370586D0 (da) 1986-08-04
MY101352A (en) 1991-09-05
DK370586A (da) 1987-03-27
MX3375A (es) 1993-12-01
FI863179A (fi) 1987-02-07
PL150228B1 (en) 1990-05-31
CN1022830C (zh) 1993-11-24
DD287502A5 (de) 1991-02-28
CN86105972A (zh) 1987-04-01
ZA865537B (en) 1987-03-25
AU6075886A (en) 1987-02-12
FI89168B (fi) 1993-05-14
ES2000706A6 (es) 1988-03-16
IE862073L (en) 1987-02-06
DE3667975D1 (en) 1990-02-08
NO863139L (no) 1987-02-09
PT83147A (en) 1986-09-01

Similar Documents

Publication Publication Date Title
GB2159516B (en) Azaphthalocyanines and their use as photoactivators
DE3666855D1 (en) Alcalisilicate compositions and their use
SG48591G (en) Phosphorus-containging amides and their use in lubricant compositions
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
EP0204659A3 (en) Polyepoxydes and their use
DE3566886D1 (en) N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
PH25019A (en) New benzamides and their use in treating gastrointestinal disorders
GB2223225B (en) Neutrophil-activating factor: its production and use in treatment
DE3660256D1 (en) Camphor-di-thiolene-complexes and their use
DE3565257D1 (en) Hydroxyalkylcycloalkylbenzeneacetamides and benzamides
ZM4886A1 (en) Medicaments and their use
EP0255801A3 (en) Anilinotriazines and their use
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
PH24632A (en) Tin diiododeuteroporphyrin and therapeutic use thereof
PH22807A (en) Benzamides and their salts
DE3666044D1 (en) Bisindoline pigments and their use
EP0201100A3 (en) Polyesters containing side chains and their use
EP0271127A3 (en) Use of guaifenesin in the treatment of urologic disorders
EP0162690A3 (en) 2-oxa-spirocyclic-benzeneacetamides and benzamides
PH23435A (en) Benzamide and application thereof in the therapeutic field
IL83838A (en) Arylethanolamines and their use for promoting production in livestock
DE3662058D1 (en) Leather-treating agent and its use
DE3561943D1 (en) Production of para-diisopropylbenzene and use of the same in the production of hydroquinone
DE3463048D1 (en) Furan-3-hydroxamates and their use
EP0318202A3 (en) Catalysts and their use in the hydrolysis of nitriles